<DOC>
	<DOC>NCT01756521</DOC>
	<brief_summary>The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc interval in healthy male subjects. Moxifloxacin is a positive control drug used in QT study. In this study, moxifloxacin 400mg and 800mg will be used, to get information on effect of moxifloxacin on QT/QTc interval.</brief_summary>
	<brief_title>A Study Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male Subjects</brief_title>
	<detailed_description>The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc interval in healthy male subjects. Moxifloxacin is a positive control drug used in QT study. In this study, moxifloxacin 400mg and 800mg will be used, (therapeutic and supratherapeutic doses) to get information on effect of moxifloxacin on QT/QTc interval in healthy Korean male subjects.</detailed_description>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>healthy male subject aged 20 to 40 at screening subjects who have weight over 50 kg with ideal body weight range of + 20% subjects who decide to participate voluntarily and write a informed consent form subjects who have acute illness within 28 days of investigational drug administration subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor subjects who have determined not eligible by screening test (medical history, physical examination, 12lead ECG, laboratory test, etc) within 28 days of study start clinically significant allergic disease (except for mild allergic rhinitis) systolic blood pressure&gt;= 140 mmHg, diastolic blood pressure &gt;= 90 mmHg, heart rate &gt; 100 bpm or &lt; 50 bpm result of 12lead electrocardiogram includes : QTcF &gt; 450 msec PR interval &gt; 200 msec or &lt;110msec Evidence of second or thirddegree atrioventricular (AV) block Pathologic Q waves (defined as Qwave &gt; 40 msec or depth &gt; 0.5 millivolt Evidence of ventricular preexcitation, left bundle branch block (LBBB), right bundle branch block (RBBB) Intraventricular conduction delay with QRS &gt; 120 msec risk of Torsade de pointes such as long QT syndrome, family history of sudden death, heart failure, hypokalemia Subjects considered unsuitable for inclusion by the investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>QT,</keyword>
	<keyword>QTc,</keyword>
	<keyword>electrocardiogram,</keyword>
	<keyword>moxifloxacin</keyword>
</DOC>